Ami Hamaguchi
YOU?
Author Swipe
View article: Pembrolizumab-associated thrombotic microangiopathy in a patient with urothelial cancer: a case report and literature review
Pembrolizumab-associated thrombotic microangiopathy in a patient with urothelial cancer: a case report and literature review Open
Background Pembrolizumab, a highly selective humanized monoclonal IgG4κ isotype antibody against PD-1, is one of the immune checkpoint inhibitors approved for treatment of various cancers. The most frequent immune-related adverse events in…